Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Keytruda in metastatic melanoma (CT Texture Analysis)
NCT02740920Phase 2Terminated
- Sponsor
- Canadian Cancer Trials Group
- Start
- Jan 2017
- Primary completion
- Mar 2019
- Countries
- 1
01
Overview
A Phase 2 trial of pembrolizumab in melanoma, sponsored by Canadian Cancer Trials Group. Started Jan 2017; status: terminated.
02
Drugs
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT02740920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02740920.